ONA Therapeutics is a startup operating in the biotechnology sector, specifically focusing on the development of therapeutic solutions for cancer treatment. The company's primary clientele includes healthcare providers and patients seeking advanced cancer treatments. ONA Therapeutics operates in a highly specialized market, where the demand for innovative and effective cancer therapies is consistently high.

The business model of ONA Therapeutics revolves around the research, development, and commercialization of novel therapies. The company invests heavily in research and development to create innovative treatments. Once a product is developed and approved for use, the company generates revenue through its sale to healthcare providers.

In terms of data protection, ONA Therapeutics adheres to the Regulation (EU) 2016/679 of the European Parliament and of the Council, ensuring the confidentiality, integrity, and security of personal data provided through its web portal. The company uses this data to respond to queries about its services and, with user consent, to send electronic information. The company does not share this data unless required by law or for services related to its information systems.

In addition, ONA Therapeutics uses cookies on its website to provide the requested service by the user. The company does not use these cookies for automated individual decisions or profiling, ensuring user privacy.

Keywords: Biotechnology, Cancer Treatment, Healthcare Providers, Research and Development, Commercialization, Data Protection, Regulation (EU) 2016/679, Confidentiality, Cookies, User Privacy.